DiDi Global Income from Continuous Operations 2021-2025 | DIDIY
DiDi Global annual/quarterly income from continuous operations history and growth rate from 2021 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- DiDi Global income from continuous operations for the quarter ending March 31, 2025 was $0.324B, a 314.05% decline year-over-year.
- DiDi Global income from continuous operations for the twelve months ending March 31, 2025 was $0.652B, a 1019.56% increase year-over-year.
- DiDi Global annual income from continuous operations for 2024 was $0.177B, a 135.29% increase from 2023.
- DiDi Global annual income from continuous operations for 2023 was $0.075B, a 102.19% decline from 2022.
- DiDi Global annual income from continuous operations for 2022 was $-3.448B, a 55.46% decline from 2021.
| DiDi Global Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $177 |
| 2023 | $75 |
| 2022 | $-3,448 |
| 2021 | $-7,742 |
| 2020 | $-1,619 |
| DiDi Global Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $324 |
| 2024-12-31 | $-36 |
| 2024-09-30 | $130 |
| 2024-06-30 | $234 |
| 2024-03-31 | $-151 |
| 2023-12-31 | $158 |
| 2023-09-30 | $52 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-134 |
| 2021-09-30 | $-4,714 |
| 2021-03-31 | $837 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $26.968B | $28.768B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.662B | 27.76 |
| CVS Health (CVS) | United States | $88.998B | 11.07 |
| Elevance Health (ELV) | United States | $69.652B | 9.37 |
| Cencora (COR) | United States | $56.292B | 18.74 |
| Labcorp Holdings (LH) | United States | $22.478B | 17.87 |
| Natera (NTRA) | United States | $22.118B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.053B | 0.00 |
| ICON (ICLR) | Ireland | $14.420B | 13.87 |
| Medpace Holdings (MEDP) | United States | $13.005B | 34.42 |
| CochLear (CHEOY) | Australia | $12.576B | 0.00 |
| Viatris (VTRS) | United States | $12.393B | 4.41 |
| Solventum (SOLV) | United States | $12.269B | 12.66 |
| Revvity (RVTY) | United States | $10.411B | 18.34 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.110B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.247B | 0.00 |
| Avantor (AVTR) | United States | $8.699B | 12.76 |
| HealthEquity (HQY) | United States | $7.742B | 33.91 |
| Charles River Laboratories (CRL) | United States | $7.726B | 14.66 |
| Bausch + Lomb (BLCO) | Canada | $5.119B | 34.43 |
| Sotera Health (SHC) | United States | $4.488B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.090B | 31.20 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.617B | 82.83 |
| Alignment Healthcare (ALHC) | United States | $3.028B | 0.00 |
| Concentras Parent (CON) | United States | $2.931B | 18.59 |
| Surgery Partners (SGRY) | United States | $2.883B | 36.27 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Progyny (PGNY) | United States | $2.045B | 43.24 |
| Premier (PINC) | United States | $2.012B | 15.27 |
| Ardent Health (ARDT) | United States | $1.806B | 6.97 |
| GoodRx Holdings (GDRX) | United States | $1.779B | 30.12 |
| PACS (PACS) | United States | $1.739B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.393B | 9.30 |
| Teladoc Health (TDOC) | United States | $1.323B | 0.00 |
| Omada Health (OMDA) | $1.204B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.108B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.788B | 4.62 |
| AMN Healthcare Services Inc (AMN) | United States | $0.745B | 9.21 |
| CareDx (CDNA) | United States | $0.631B | 11.62 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.525B | 7.95 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.477B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| SBC Medicals (SBC) | United States | $0.439B | 9.64 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 26.57 |
| So-Young (SY) | China | $0.367B | 0.00 |
| Oncology Institute (TOI) | United States | $0.361B | 0.00 |
| LifeMD (LFMD) | United States | $0.309B | 0.00 |
| Beauty Health (SKIN) | United States | $0.278B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| KindlyMD (NAKA) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |